Co-expression of putative cancer stem cell markers, CD133 and Nestin, in skin tumors

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 19, 2014, Pages 8161-8169

  Sabet, Mehrdad Nasrollahzadeh ^a   Rakhshan, Azadeh ^b   Erfani, Elham ^c   Madjd, Zahra ^a,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

BCC; Cancer stem cells; CD133; Melanoma; Nestin; SCC

Indexed keywords

CD133 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; NES PROTEIN, HUMAN; NESTIN; PEPTIDE; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; BASAL CELL CARCINOMA; CANCER STAGING; CANCER STEM CELL; CHILD; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HUMAN; MALE; MELANOMA; METABOLISM; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GLYCOPROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; NEOPLASTIC STEM CELLS; NESTIN; PEPTIDES; PROGNOSIS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84908377273     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.19.8161     Document Type: Article

References (65)

1. Abbas O, Bhawan J (2011). Expression of stem cell markers Nestin and cytokeratin 15 and 19 in cutaneous malignancies. J Eur Acad Dermatol Venereol, 25, 311-16.
2. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al (2003). Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA, 100, 3983-88.
3. Al Dhaybi R, Sartelet H, Powell J, et al (2010). Expression of CD133+ cancer stem cells in childhood malignant melanoma and its correlation with metastasis. Mod Pathol, 23, 376-80.
4. Andrade P, Brites MM, Vieira R, et al (2012). Epidemiology of basal cell carcinomas and squamous cell carcinomas in a Department of Dermatology: a 5year review. An Bras Dermatol, 87, 212-19.
5. Bapat SA, Mali AM, Koppikar CB, et al (2005). Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res, 65, 3025-9.
6. Belicchi M, Pisati F, Lopa R, et al (2004). Human skin-derived stem cells migrate throughout forebrain and differentiate into astrocytes after injection into adult mouse brain. J Neurosci Res, 77, 475-86.
7. Blackwood MA, Holmes R, Synnestvedt M, et al (2002). Multiple primary melanoma revisited. Cancer, 94, 2248-55.
8. Boiko AD, Razorenova OV, van de Rijn M, et al (2010). Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature, 466, 133-7.
9. Bongiorno MR, Doukaki S, Malleo F, et al (2008). Identification of progenitor cancer stem cell in lentigo maligna melanoma. Dermatol Ther, 21, 1-5.
10. Bonnet D, Dick JE (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med, 3,730-7.
11. Civenni G, Walter A, Kobert N, et al (2011). Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res, 71, 3098-109.
12. Clarke MF, Dick JE, Dirks PB, et al (2006). Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res, 66, 9339-344.
13. Clarke MF, Fuller M (2006). Stem cells and cancer: two faces of eve. Cell, 124, 1111-15.
14. Collins AT, Berry PA, Hyde C, et al (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res, 65, 10946-951.
15. Dahlstrand J, Zimmerman LB, McKay RD, et al (1992). Characterization of the human Nestin gene reveals a close evolutionary relationship to neurofilaments. J Cell Sci, 103, 589-97.
16. Fang D, Nguyen TK, Leishear K, et al (2005). A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res, 65, 9328-37.
17. Fernandez-Figueras MT, Ariza A, Calatrava A, et al. (1996). CD44 and melanocytic tumors: a possible role for standard CD44 in the epidermotropic spread of melanoma. J Cutan Pathol, 23, 133-9.
18. Florenes VA, Holm R, Myklebost O, et al (1994). Expression of the neuroectodermal intermediate filament Nestin in human melanomas. Cancer Res, 54, 354-6.
19. Frank NY, Margaryan A, Huang Y, et al (2005). ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res, 65, 4320-33.
20. Frank NY, Pendse SS, Lapchak PH, et al (2003). Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter. J Biol Chem, 278, 47156-65.
21. Fusi A, Reichelt U, Busse A, et al (2011). Expression of the stem cell markers Nestin and CD133 on circulating melanoma cells. J Invest Dermatol, 131, 487-94.
22. Gajda M, Kaminska-winciorek G (2014). Do not let to be late: overview of reasons for melanoma delayed diagnosis. Asian Pac J Cancer Prev, 15, 3873-7.
23. Gyrylova SN, Aksenenko MB, Gavrilyuk DV, et al (2014). Melanoma incidence mortality rates and clinico-pathological types in the Siberian area of the Russian Federation. Asian Pac J Cancer Prev, 15, 2201-4.
24. Hamburger A W, Salmon SE (1977). Primary bioassay of human tumor stem cells. Science, 197, 461-3.
25. Hemmati HD, Nakano I, Lazareff JA, et al (2003). Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA, 100, 15178-183.
26. Houghton J, Stoicov C, Nomura S, et al (2004). Gastric cancer originating from bone marrow-derived cells. Science, 306, 1568-71.
27. Ishiwata T, Matsuda Y, Naito Z (2011). Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis. World J Gastroenterol, 17, 409-18.
28. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
29. Keshet G I, Goldstein I, Itzhaki O, et al (2008). MDR1 expression identifies human melanoma stem cells. Biochem Biophys Res Commun, 368, 930-6.
30. Kim CF, Jackson EL, Woolfenden AE, et al (2005). Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell, 121, 823-35.
31. Klein Wm, Wu BP, Zhao S, et al (2006). Increased expression of stem cell markers in malignant melanoma. Mod Pathol, 20, 102-7.
32. Kononen J, Bubendorf L, Kallioniemi A, et al (1998). Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med, 4, 844-7.
33. La Porta CA, Zapperi S (2013). Human breast and melanoma cancer stem cells biomarkers. Cancer Lett, 338, 69-73
34. Ladstein RG, Bachmann IM, Straume Om, et al (2014). Nestin expression is associated with aggressive cutaneous melanoma of the nodular type. Mod Pathol, 27, 396-401.
35. Laga AC, Zhan Q, Weishaupt C, et al (2011). SOX2 and Nestin expression in human melanoma: an immunohistochemical and experimental study. Exp Dermatol, 20, 339-45.
36. Leiter U, Garbe C (2008). Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight. Adv Exp Med Biol, 624, 89-103.
37. Lendahl U, Zimmerman LB, McKay RD (1990). CNS stem cells express a new class of intermediate filament protein. Cell, 60, 585-95.
38. Li JC, Liu D, Yang Y, et al (2013). Growth, clonability, and radiation resistance of esophageal carcinoma-derived stem-like cells. Asian Pac J Cancer Prev: APJCP, 14, 4891-6.
39. Madjd Z, Karimi A, Molanae S, et al (2011). BRCA1 protein expression level and CD44 (+) phenotype in breast cancer patients. Cell Journal, 13, 155-62.
40. Mehrazma M, Madjd Z, Kalantari E, et al (2013). Expression of stem cell markers, CD133 and CD44, in pediatric solid tumors: a study using tissue microarray. Fetal Pediatr Pathol, 32, 192-204.
41. Mohsenzadegan M, Madjd Z, Asgari M, et al (2013). Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis. Cancer Immunol Immunother, 62, 1609-18.
42. Monzani E, Facchetti F, Galmozzi E, et al (2007). Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer, 43, 935-46.
43. Mueller DW, Bosserhoff AK (2009). Role of miRNAs in the progression of malignant melanoma. Br J Cancer, 101, 551-6.
44. Passegue E, Jamieson CH, Ailles LE, et al (2003). Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc Natl Acad Sci USA, 100, 11842-9.
45. Patel M, Lu L, Zande DS, et al (2008). ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors. Lung Cancer, 59, 340-9.
46. Piras F, Perra MT, Murtas D, et al (2010). The stem cell marker Nestin predicts poor prognosis in human melanoma. Oncol Rep, 23, 17-24.
47. Ponti D, Costa A, Zaffaroni N, et al (2005). Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res, 65, 5506-11.
48. Porta C (2009). Cancer stem cells: lessons from melanoma. Stem Cell Reviews Reports, 5, 61-5.
49. Quintana E, Shackleton M, Foster Hannah R, et al (2010). Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell, 18, 510-23.
50. Rajabpour FV, Raoofian R, Youssefian L, et al (2014). BMI1 and TWIST1 downregulated mRNA expression in basal cell carcinoma. Asian Pac J Cancer Prev, 15, 3797-800.
51. Rangwala F, Omenetti A, Diehl AM (2011). Cancer stem cells: repair gone awry? J Oncol, 2011, 465343
52. Rappa G, Fodstad O, Lorico A (2008). The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. STEM CELLS, 26, 3008-17.
53. Reya T, Morrison SJ, Clarke MF, et al (2001). Stem cells, cancer, and cancer stem cells. Nature, 414, 105-11.
54. Satpute PS, Hazarey V, Ahmed R, et al (2013). Cancer stem cells in head and neck squamous cell carcinoma: A review. Asian Pac J Cancer Prev, 14, 5579-87.
55. Schatton T, Murphy GF, Frank NY, et al (2008). Identification of cells initiating human melanomas. Nature, 451, 345-9.
56. Semnani V, Toussy JA, Soltany S, et al (2008). Epidemiologic pattern of skin malignancies in semnan, Iran between 1999 and 2007 and comparing it with meta-analysis of published papers in world between 2000 and 2008.
57. Shakhova O, Sommer L (2013). Testing the cancer stem cell hypothesis in melanoma: The clinics will tell. Cancer Lett, 338, 74-81.
58. Sharma BK, Manglik V, Elias E George (2010). Immuno-expression of human melanoma stem cell markers in tissues at different stages of the disease. J Surg Res, 163, 11-15.
59. Shmelkov SV, St Clair R, Lyden D, et al (2005). AC133/CD133/Prominin-1. Int J Biochem Cell Biol, 37, 715-19.
60. Siclari VA, Qin L (2010). Targeting the osteosarcoma cancer stem cell. J Orthop Surg Res, 5, 78.
61. Singh SK, Clarke ID, Terasaki M, et al (2003). Identification of a cancer stem cell in human brain tumors. Cancer Res, 63, 5821-8.
62. Tanabe K, Amoh Y, Kanoh M, et al (2010). Prognostic significance of the hair follicle stem cell marker Nestin in patients with malignant melanoma. Eur J Dermatol, 20, 283-8.
63. Thill M, Berna MJ, Grierson R, et al (2011). Expression of CD133 and other putative stem cell markers in uveal melanoma. Melanoma Res, 21, 405-16.
64. Tohyama T, Lee VM, Rorke LB, et al (1992). Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells. Lab Invest, 66, 303-13.
65. Wang Q, Chen ZG, Du CZ, et al (2009). Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer. Histopathology, 55, 284-93.